🇺🇸 FDA
Patent

US 11718618

Substituted pyrido[2,1-a]isoquinolines as VMAT2 inhibitors

granted A61PA61P25/00A61P25/18

Quick answer

US patent 11718618 (Substituted pyrido[2,1-a]isoquinolines as VMAT2 inhibitors) held by Neurocrine Biosciences, Inc. expires Mon Aug 03 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Neurocrine Biosciences, Inc.
Grant date
Tue Aug 08 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Aug 03 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
28
CPC classes
A61P, A61P25/00, A61P25/18